A Genetic Screen for Temperature-sensitive Morphogenesis-defective Caenorhabditis elegans Mutants
Congratulations to Bruce A. Bowerman, one of our esteemed customer published a paper this week in G3: Genes, Genomes,
Get a better understanding and prediction for pre-clinical drug trials
Allowing comprehension and predicting of human responses earlier, while also offering ethical alternatives to animal testing.
Congratulations to Bruce A. Bowerman, one of our esteemed customer published a paper this week in G3: Genes, Genomes,
THE GENETICS OF CAENORHABDITIS ELEGANS (1974) Brenner shed light on the Caenorhabditis elegans in 1974 with his study demonstrating
A step for the development of the CubiX product line Congratulation to Dr. W. Kaelin, Dr.
CubiX was presented in Adelaide Thanks to Benjamin Thierry and The South Australian Government Department of
Cherry Biotech is in Adelaide : Cherry Biotech is at the University of South Australia (Adelaide) until June 22 to discuss and collaborate
Dr. Dario Fassini introduces our new CubiX product line on BioChip Berlin conference This Tuesday, May
Yannick Jadot mentions Cherry Biotech technologies Cherry Biotech Organ-on-a-Chip technologies mentioned as an alternative to animal drug testing
Together with our ecosystem at the NBIC valley, we were asked to particiate as expert on
Cherry Biotech will be there with Cherry Temp platform ! The meeting will take place at a convention
Cherry Biotech @Rennes Meeting the mayor 17th May 2018 Rencontre avec La maire INNOVATION ET PARTENAIRES
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com